학술논문
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal study
Document Type
Article
Author
Rodziewicz, M.; Dyball, S.; Lunt, M.; McDonald, S.; Sutton, E.; Parker, B.; Bruce, I.N.; Abernethy, R.; Ahmad, Y.; Akil, M.; Bartram, S.; Batley, M.; Bharadwaj, A.; Carlucci, F.; Chan, A.; Dasgupta, B.; D'Cruz, D.; De Lord, D.; Dyke, B.; Edwards, C.; Erb, N.; Farrell, A.; Gayed, M.; Gendi, N.; Gompels, L.; Gordon, C.; Gordon, P.; Griffiths, B.; Gullick, N.; Gunwardena, H.; Haigh, R.; Hamdulay, S.; Haque, S.; Hutchinson, D.; Isenberg, D.; Jayne, D.; Jeffery, R.; Kapur, D.; Kaul, A.; King, J.; Knights, S.; Korendowych, E.; Lanyon, P.; Mahindrakar, M.; Marks, J.; McCann, L.; McLaren, Z.; Mediwake, R.; Menon, A.; Mewar, D.; Min, S.Y.; Nair, J.; O'Riordan, E.; Pyne, D.; Rahmeh, F.; Regan, M.; Reynolds, J.; Rhodes, B.; Rhys-Dillon, C.; Robson, J.C.; Shaffu, S.; Sheeran, T.; Skeoch, S.; Sood, B.R.; Stratton, R.; Teh, L.-S.; Vermaak, E.; Vital, E.; Waller, R.; Watts, R.; Wijeyekoon, J.; Yee, C.-S.; Yong, C.Y.; Youssef, H.; Yusuf, A.; Zoma, A.
Source
In: The Lancet Rheumatology . (The Lancet Rheumatology, May 2023, 5(5):e284-e292)
Subject
Language
English
ISSN
26659913